percentage of people on glp 1 Products - Data Briefs - Number 537 GLP-1 Survey: 37.5% of People
Description
Increases GLP-1 naturally* *Based on preclinical studies Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which induce GLP-1 production

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

GLP-1 drugs are easier to get now, but Lowcountry doctors say they work best with medical guidance, nutrition support and the right reasons.

By promoting the growth of beneficial bacteria and supporting short-chain fatty acid (SCFA) production, GLP-Balance helps create a favorable environment for satiety, nutrient absorption, and weight management.*

Pharmacognosy Res
